These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38515943)

  • 21. Multidisciplinary treatment of colorectal liver metastases.
    Schiergens TS; von Einem J; Thomas MN; Albertsmeier M; Giessen-Jung C; Dörsch M; Heiliger C; Drefs M; Andrassy J; Modest DP; Stintzing S; Guba M; Angele M; Werner J; Rentsch M
    Minerva Med; 2017 Dec; 108(6):527-546. PubMed ID: 28889727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies.
    Nigri G; Petrucciani N; Ferla F; La Torre M; Aurello P; Ramacciato G
    Surgeon; 2015 Apr; 13(2):83-90. PubMed ID: 25257725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
    Popescu I; Alexandrescu S
    Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
    Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis.
    Liu W; Zhou JG; Sun Y; Zhang L; Xing BC
    Oncotarget; 2016 Jun; 7(24):37277-37287. PubMed ID: 27074564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
    Takatsuki M; Tokunaga S; Uchida S; Sakoda M; Shirabe K; Beppu T; Emi Y; Oki E; Ueno S; Eguchi S; Akagi Y; Ogata Y; Baba H; Natsugoe S; Maehara Y;
    Eur J Surg Oncol; 2016 Feb; 42(2):184-9. PubMed ID: 26683263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study.
    Behrenbruch C; Prabhakaran S; Udayasiri D; Hollande F; Michael M; Hayes I; Heriot A; Knowles B; Thomson B
    ANZ J Surg; 2021 Jun; 91(6):1196-1202. PubMed ID: 33543551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.
    Lim E; Thomson BN; Heinze S; Chao M; Gunawardana D; Gibbs P
    ANZ J Surg; 2007 Nov; 77(11):941-7. PubMed ID: 17931254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
    Kuiper BI; Abu Hilal M; Aldrighetti LA; Björnsson B; D'Hondt M; Dopazo C; Fretland ÅA; Isoniemi H; Philip Jonas J; Kazemier G; Lesurtel M; Primrose J; Schnitzbauer AA; Buffart T; Gruenberger B; Swijnenburg RJ; Gruenberger T
    HPB (Oxford); 2024 May; 26(5):639-647. PubMed ID: 38373870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative chemotherapy for resectable colorectal liver metastases: where now?
    Jones RP; Malik HZ; Fenwick SW; Poston GJ
    Eur J Surg Oncol; 2013 Aug; 39(8):807-11. PubMed ID: 23726258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.
    Gur I; Diggs BS; Wagner JA; Vaccaro GM; Lopez CD; Sheppard BC; Orloff SL; Billingsley KG
    J Gastrointest Surg; 2013 Dec; 17(12):2133-42. PubMed ID: 24091909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive Factors for the Survival Outcomes of Preoperative Chemotherapy in Patients with Resectable and Borderline Resectable Colorectal Cancer with Liver Metastasis.
    Inworn N; Senavat P; Aleenajitpong N; Chingchaimaneesri M; Siripoon T; Srirattanapong S; Suragul W; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3037-3047. PubMed ID: 37774055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
    Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oncosurgical strategies for metastatic liver cancer].
    Adam R; Hoti E; Bredt LC
    Cir Esp; 2011 Jan; 89(1):10-9. PubMed ID: 21176894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
    Popescu I; Alexandrescu S; Croitoru A; Boros M
    Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.
    Nakanishi M; Kuriu Y; Murayama Y; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Otsuji E
    Hepatogastroenterology; 2014 Sep; 61(134):1582-7. PubMed ID: 25436346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.